Genus Plc (GENSY) Stock Price, News & Analysis
Company Description
Genus Plc (OTC Link: GENSY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.0B.
GENSY has gained 16.6% over the past year. Shares last traded at $28.38.
This page collects what Stock Titan holds for GENSY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genus Plc (GENSY) stock last closed at $28.38. Over the past 12 months, the stock has gained 16.6%. At a market capitalization of $2.0B, GENSY is classified as a small-cap stock with approximately 66.5M shares outstanding.
Latest News
Genus Plc has 5 recent news articles. Key topics include acquisition, AI. View all GENSY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Genus Plc (GENSY) currently stands at 94 shares, down 22.3% from the previous reporting period, representing 0.0% of the shares outstanding.
Days to Cover History
Days to cover for Genus Plc (GENSY) currently stands at 3.1 days, up 213% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 46.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GENSY Company Profile & Sector Positioning
Genus Plc (GENSY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GENSY often look at related companies in the same sector, including Northwest Bio (NWBO), Cytodyn Inc (CYDY), Clinuvl Phrmaceu (CLVLY), Nuo Therapeutics (AURX), and Alk-Abello A/S (AKBLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GENSY's relative position within its industry.